Cargando…
A novel HIV vaccine targets the 12 protease cleavage sites
Autores principales: | Luo, M, Tang, D, Capina, R, Yuan, X, Prego, C, Pinto, JC, Alonso, M, Barry, C, Pilon, R, Daniuk, C, Tuff, J, Pillet, S, La, D, Bielawny, T, Czarnecki, C, Lacap, P, Peters, H, Wong, G, Kimani, M, Wachihi, C, Kimani, J, Ball, TB, Sandstrom, P, Kobinger, G, Plummer, FA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441448/ http://dx.doi.org/10.1186/1742-4690-9-S2-P304 |
Ejemplares similares
-
P16-15. Epitope mapping of HIV-specific CD8+ T-cells responses by polyfunctional and proliferation responses reveal distinct specificity defined by function
por: Richmond, ME, et al.
Publicado: (2009) -
T cell immune quiescence as a contributor to resistance to infection among HIV Exposed Seronegative (HESN) commercial sex workers from Nairobi, Kenya
por: Fowke, KR, et al.
Publicado: (2012) -
Influence of HLA Class I Haplotypes on HIV-1 Seroconversion and Disease Progression in Pumwani Sex Worker Cohort
por: Sampathkumar, Raghavan, et al.
Publicado: (2014) -
HIV-1 Clade D Is Associated with Increased Rates of CD4 Decline in a Kenyan Cohort
por: McKinnon, Lyle R., et al.
Publicado: (2012) -
P16-27.Optimization of the expansion of antigen-specific CD8+ T-cells for use in a viral suppression assay
por: Herman, MM, et al.
Publicado: (2009)